In this episode, we meet with Dr. Suresh Muthukumaraswamy, an Associate Professor of Pharmacy in Auckland. Dr. Muthukumaraswamy discusses his early research, exploring the functional connectivity of substances like DMT and Ketamine. He proceeds to share insights into his breakthrough realisation regarding the disparity between the self-reported success of microdosing outside the lab setting and why it has failed to be replicated in controlled research settings. Finally, he shares his opinions on recent developments of drug policy in Australia and the prospects of New Zealand adopting a similar policy.
Australia Law on MDMA and Psilocybin